Pancreas, volume 39, issue 4, pages 425-435

Phenotype and Genotype of Pancreatic Cancer Cell Lines

Deer Emily L. 1
González-Hernández Jessica 2, 3
Coursen Jill D. 3
Shea Jill E. 3
Ngatia Josephat 3, 4
Scaife Courtney L 3
Firpo Matthew A. 3
Mulvihill Sean J. 3
1
 
Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT, 84132, USA.
2
 
University of Puerto Rico
3
 
University Of Utah
4
 
University Of Florida
Publication typeJournal Article
Publication date2010-04-16
Journal: Pancreas
Quartile SCImago
Q2
Quartile WOS
Q3
Impact factor2.9
ISSN08853177, 15364828
Endocrinology
Endocrinology, Diabetes and Metabolism
Hepatology
Internal Medicine
Abstract
Abstract The dismal prognosis of pancreatic adenocarcinoma is due in part to a lack of molecular information regarding disease development. Established cell lines remain a useful tool for investigating these molecular events. Here we present a review of available information on commonly used pancreatic adenocarcinoma cell lines as a resource to help investigators select the cell lines most appropriate for their particular research needs. Information on clinical history; in vitro and in vivo growth characteristics; phenotypic characteristics, such as adhesion, invasion, migration, and tumorigenesis; and genotypic status of commonly altered genes (KRAS, p53, p16, and SMAD4) was evaluated. Identification of both consensus and discrepant information in the literature suggests careful evaluation before selection of cell lines and attention be given to cell line authentication.

Citations by journals

5
10
15
20
25
30
35
Cancers
Cancers, 34, 4.86%
Cancers
34 publications, 4.86%
Oncotarget
Oncotarget, 30, 4.29%
Oncotarget
30 publications, 4.29%
PLoS ONE
PLoS ONE, 28, 4.01%
PLoS ONE
28 publications, 4.01%
Scientific Reports
Scientific Reports, 22, 3.15%
Scientific Reports
22 publications, 3.15%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 18, 2.58%
International Journal of Molecular Sciences
18 publications, 2.58%
Pancreas
Pancreas, 15, 2.15%
Pancreas
15 publications, 2.15%
Cancer Research
Cancer Research, 13, 1.86%
Cancer Research
13 publications, 1.86%
Cells
Cells, 12, 1.72%
Cells
12 publications, 1.72%
Cancer Letters
Cancer Letters, 12, 1.72%
Cancer Letters
12 publications, 1.72%
Advances in Biological Regulation
Advances in Biological Regulation, 9, 1.29%
Advances in Biological Regulation
9 publications, 1.29%
BMC Cancer
BMC Cancer, 8, 1.14%
BMC Cancer
8 publications, 1.14%
International Journal of Oncology
International Journal of Oncology, 7, 1%
International Journal of Oncology
7 publications, 1%
Biomedicines
Biomedicines, 7, 1%
Biomedicines
7 publications, 1%
Frontiers in Oncology
Frontiers in Oncology, 7, 1%
Frontiers in Oncology
7 publications, 1%
Cancer Cell International
Cancer Cell International, 7, 1%
Cancer Cell International
7 publications, 1%
Oncology Reports
Oncology Reports, 6, 0.86%
Oncology Reports
6 publications, 0.86%
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology, 6, 0.86%
Frontiers in Cell and Developmental Biology
6 publications, 0.86%
Journal of Experimental and Clinical Cancer Research
Journal of Experimental and Clinical Cancer Research, 6, 0.86%
Journal of Experimental and Clinical Cancer Research
6 publications, 0.86%
Nature Communications
Nature Communications, 6, 0.86%
Nature Communications
6 publications, 0.86%
Carcinogenesis
Carcinogenesis, 6, 0.86%
Carcinogenesis
6 publications, 0.86%
Clinical Cancer Research
Clinical Cancer Research, 6, 0.86%
Clinical Cancer Research
6 publications, 0.86%
Frontiers in Immunology
Frontiers in Immunology, 5, 0.72%
Frontiers in Immunology
5 publications, 0.72%
Cellular oncology (Dordrecht)
Cellular oncology (Dordrecht), 5, 0.72%
Cellular oncology (Dordrecht)
5 publications, 0.72%
Cell Reports
Cell Reports, 5, 0.72%
Cell Reports
5 publications, 0.72%
International Journal of Pharmaceutics
International Journal of Pharmaceutics, 5, 0.72%
International Journal of Pharmaceutics
5 publications, 0.72%
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics, 5, 0.72%
Molecular Cancer Therapeutics
5 publications, 0.72%
Aging
Aging, 4, 0.57%
Aging
4 publications, 0.57%
Cell Death and Disease
Cell Death and Disease, 4, 0.57%
Cell Death and Disease
4 publications, 0.57%
Oncogene
Oncogene, 4, 0.57%
Oncogene
4 publications, 0.57%
5
10
15
20
25
30
35

Citations by publishers

20
40
60
80
100
120
140
Elsevier
Elsevier, 124, 17.74%
Elsevier
124 publications, 17.74%
Springer Nature
Springer Nature, 120, 17.17%
Springer Nature
120 publications, 17.17%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 89, 12.73%
Multidisciplinary Digital Publishing Institute (MDPI)
89 publications, 12.73%
Wiley
Wiley, 50, 7.15%
Wiley
50 publications, 7.15%
Impact Journals
Impact Journals, 34, 4.86%
Impact Journals
34 publications, 4.86%
Public Library of Science (PLoS)
Public Library of Science (PLoS), 29, 4.15%
Public Library of Science (PLoS)
29 publications, 4.15%
American Association for Cancer Research (AACR)
American Association for Cancer Research (AACR), 29, 4.15%
American Association for Cancer Research (AACR)
29 publications, 4.15%
Frontiers Media S.A.
Frontiers Media S.A., 22, 3.15%
Frontiers Media S.A.
22 publications, 3.15%
Wolters Kluwer Health
Wolters Kluwer Health, 20, 2.86%
Wolters Kluwer Health
20 publications, 2.86%
American Chemical Society (ACS)
American Chemical Society (ACS), 17, 2.43%
American Chemical Society (ACS)
17 publications, 2.43%
Spandidos Publications
Spandidos Publications, 14, 2%
Spandidos Publications
14 publications, 2%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 14, 2%
Royal Society of Chemistry (RSC)
14 publications, 2%
Taylor & Francis
Taylor & Francis, 13, 1.86%
Taylor & Francis
13 publications, 1.86%
SAGE
SAGE, 8, 1.14%
SAGE
8 publications, 1.14%
Oxford University Press
Oxford University Press, 6, 0.86%
Oxford University Press
6 publications, 0.86%
American Society for Biochemistry and Molecular Biology
American Society for Biochemistry and Molecular Biology, 5, 0.72%
American Society for Biochemistry and Molecular Biology
5 publications, 0.72%
Hindawi Limited
Hindawi Limited, 5, 0.72%
Hindawi Limited
5 publications, 0.72%
AME Publishing Company
AME Publishing Company, 5, 0.72%
AME Publishing Company
5 publications, 0.72%
Mary Ann Liebert
Mary Ann Liebert, 4, 0.57%
Mary Ann Liebert
4 publications, 0.57%
American Association for the Advancement of Science (AAAS)
American Association for the Advancement of Science (AAAS), 4, 0.57%
American Association for the Advancement of Science (AAAS)
4 publications, 0.57%
Baishideng Publishing Group
Baishideng Publishing Group, 3, 0.43%
Baishideng Publishing Group
3 publications, 0.43%
Proceedings of the National Academy of Sciences (PNAS)
Proceedings of the National Academy of Sciences (PNAS), 3, 0.43%
Proceedings of the National Academy of Sciences (PNAS)
3 publications, 0.43%
Pleiades Publishing
Pleiades Publishing, 2, 0.29%
Pleiades Publishing
2 publications, 0.29%
Neoplasia Press, 2, 0.29%
Neoplasia Press
2 publications, 0.29%
Federation of American Societies for Experimental Biology (FASEB)
Federation of American Societies for Experimental Biology (FASEB), 2, 0.29%
Federation of American Societies for Experimental Biology (FASEB)
2 publications, 0.29%
American Society for Microbiology
American Society for Microbiology, 2, 0.29%
American Society for Microbiology
2 publications, 0.29%
Walter de Gruyter
Walter de Gruyter, 2, 0.29%
Walter de Gruyter
2 publications, 0.29%
eLife Sciences Publications
eLife Sciences Publications, 2, 0.29%
eLife Sciences Publications
2 publications, 0.29%
Rockefeller University Press
Rockefeller University Press, 2, 0.29%
Rockefeller University Press
2 publications, 0.29%
20
40
60
80
100
120
140
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Deer E. L. et al. Phenotype and Genotype of Pancreatic Cancer Cell Lines // Pancreas. 2010. Vol. 39. No. 4. pp. 425-435.
GOST all authors (up to 50) Copy
Deer E. L., González-Hernández J., Coursen J. D., Shea J. E., Ngatia J., Scaife C. L., Firpo M. A., Mulvihill S. J. Phenotype and Genotype of Pancreatic Cancer Cell Lines // Pancreas. 2010. Vol. 39. No. 4. pp. 425-435.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1097/MPA.0b013e3181c15963
UR - https://doi.org/10.1097%2FMPA.0b013e3181c15963
TI - Phenotype and Genotype of Pancreatic Cancer Cell Lines
T2 - Pancreas
AU - Deer, Emily L.
AU - González-Hernández, Jessica
AU - Coursen, Jill D.
AU - Shea, Jill E.
AU - Ngatia, Josephat
AU - Scaife, Courtney L
AU - Firpo, Matthew A.
AU - Mulvihill, Sean J.
PY - 2010
DA - 2010/04/16 00:00:00
PB - Wolters Kluwer Health
SP - 425-435
IS - 4
VL - 39
PMID - 20418756
SN - 0885-3177
SN - 1536-4828
ER -
BibTex |
Cite this
BibTex Copy
@article{2010_Deer
author = {Emily L. Deer and Jessica González-Hernández and Jill D. Coursen and Jill E. Shea and Josephat Ngatia and Courtney L Scaife and Matthew A. Firpo and Sean J. Mulvihill},
title = {Phenotype and Genotype of Pancreatic Cancer Cell Lines},
journal = {Pancreas},
year = {2010},
volume = {39},
publisher = {Wolters Kluwer Health},
month = {apr},
url = {https://doi.org/10.1097%2FMPA.0b013e3181c15963},
number = {4},
pages = {425--435},
doi = {10.1097/MPA.0b013e3181c15963}
}
MLA
Cite this
MLA Copy
Deer, Emily L., et al. “Phenotype and Genotype of Pancreatic Cancer Cell Lines.” Pancreas, vol. 39, no. 4, Apr. 2010, pp. 425-435. https://doi.org/10.1097%2FMPA.0b013e3181c15963.
Found error?